Burning Rock Biotech Ltd (BNR) stock
BNRNasdaqServices-Medical Laboratories
$13.07+0.57 (+4.56%)
Close on Nov 18, 2026Market cap $142.28MP/E –Yield –
Burning Rock Biotech revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was CN¥539.57M, up 4.6% from the year before. The highest annual figure on record is CN¥563.24M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CN¥539.57M | +4.6% |
| FY2024 | Dec 31, 2024 | CN¥515.82M | -4.0% |
| FY2023 | Dec 31, 2023 | CN¥537.44M | -4.6% |
| FY2022 | Dec 31, 2022 | CN¥563.24M | +10.9% |
| FY2021 | Dec 31, 2021 | CN¥507.86M | +18.1% |
| FY2020 | Dec 31, 2020 | CN¥429.90M | +12.6% |
| FY2019 | Dec 31, 2019 | CN¥381.68M | +82.7% |
| FY2018 | Dec 31, 2018 | CN¥208.87M | – |
See a number that looks wrong?